Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD.
- DOI
- 10.1016/j.ejphar.2025.177945
- Published
- 2025 Sep 15
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2025.177945,
title = {Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD.},
author = {Briand F and Dubroca C and Wettstein G and Grasset E and Breyner N and Bigot C and Assaly R and Broqua P and Sulpice T},
year = {2025},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2025.177945},
url = {https://doi.org/10.1016/j.ejphar.2025.177945}
}RIS
TY - JOUR TI - Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD. AU - Briand F AU - Dubroca C AU - Wettstein G AU - Grasset E AU - Breyner N AU - Bigot C AU - Assaly R AU - Broqua P AU - Sulpice T PY - 2025 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2025.177945 UR - https://doi.org/10.1016/j.ejphar.2025.177945 ER -
APA
F, B., C, D., G, W., E, G., N, B., C, B., R, A., P, B., & T, S. (2025). Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2025.177945
Source records
- pubmed · retrieved 2026-09-26T22:38:03.540Z